ReviewCancer

The hallmarks of successful anticancer immunotherapy

See allHide authors and affiliations

Science Translational Medicine  19 Sep 2018:
Vol. 10, Issue 459, eaat7807
DOI: 10.1126/scitranslmed.aat7807

Article Information

vol. 10 no. 459

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication April 14, 2018
  • Accepted for publication July 27, 2018

Author Information

  1. Lorenzo Galluzzi1,2,3,*,
  2. Timothy A. Chan4,5,6,
  3. Guido Kroemer3,7,8,9,10,11,12,
  4. Jedd D. Wolchok6,13 and
  5. Alejandro López-Soto14,*
  1. 1Department of Radiation Oncology, Weill Cornell Medical College, New York, NY 10065, USA.
  2. 2Sandra and Edward Meyer Cancer Center, New York, NY 10065, USA.
  3. 3Université Paris Descartes/Paris V, 75006 Paris, France.
  4. 4Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  5. 5Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  6. 6Weill Cornell School of Medicine, New York, NY 10065, USA.
  7. 7Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, 75006 Paris, France.
  8. 8INSERM, U1138, 75006 Paris, France.
  9. 9Université Pierre et Marie Curie/Paris VI, 75006 Paris, France.
  10. 10Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Center, 94805 Villejuif, France.
  11. 11Pôle de Biologie, Hôpital Européen Georges-Pompidou, Assistance Publique–Hôpitaux de Paris, 75015 Paris, France.
  12. 12Department of Women’s and Children’s Health, Karolinska University Hospital, 17176 Stockholm, Sweden.
  13. 13Department of Medicine, Parker Institute and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  14. 14Departamento de Biología Funcional, Área de Inmunología, Universidad de Oviedo, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33006 Oviedo, Spain.
  1. *Corresponding author. Email: deadoc{at}vodafone.it (L.G.); lopezsalejandro{at}uniovi.es (A.L.-S.)

Altmetric

Article usage

Article usage: September 2018 to April 2019

AbstractFullPdf
Sep 2018468118646314
Oct 201825959801201
Nov 20181743282342
Dec 20181431186285
Jan 2019832200238
Feb 2019623187187
Mar 2019771146212
Apr 2019520102144